Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation
Open Access

Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model

Mark S. Longtine, Kyuhwan Shim, Mark J. Hoegger, Nadia Benabdallah, Diane S. Abou, Daniel L.J. Thorek and Richard L. Wahl
Journal of Nuclear Medicine June 2023, 64 (6) 924-931; DOI: https://doi.org/10.2967/jnumed.122.265167
Mark S. Longtine
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyuhwan Shim
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Hoegger
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia Benabdallah
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane S. Abou
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel L.J. Thorek
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
2Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
3Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 6 924-931
DOI 
https://doi.org/10.2967/jnumed.122.265167
PubMed 
37024304

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication November 14, 2022
  • Revision received February 2, 2023
  • Published online June 1, 2023.

Article Versions

  • previous version (April 6, 2023 - 12:24).
  • previous version (April 20, 2023 - 12:23).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

  1. Mark S. Longtine*,1,
  2. Kyuhwan Shim*,1,
  3. Mark J. Hoegger1,
  4. Nadia Benabdallah1,
  5. Diane S. Abou1,
  6. Daniel L.J. Thorek1,2 and
  7. Richard L. Wahl1,3
  1. 1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
  2. 2Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri; and
  3. 3Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
  1. For correspondence or reprints, contact Richard Wahl (rwahl{at}wustl.edu).
  1. ↵* Contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • 10 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
    Mark S. Longtine, Kyuhwan Shim, Mark J. Hoegger, Nadia Benabdallah, Diane S. Abou, Daniel L.J. Thorek, Richard L. Wahl
    Journal of Nuclear Medicine 2023 64 6
  • CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma
    Anju Wadhwa, Sinan Wang, Bonell Patiño-Escobar, Anil P. Bidkar, Kondapa Naidu Bobba, Emily Chan, Niranjan Meher, Scott Bidlingmaier, Yang Su, Suchi Dhrona, Huimin Geng, Vishesh Sarin, Henry F. VanBrocklin, David M. Wilson, Jiang He, Li Zhang, Veronica Steri, Sandy W. Wong, Thomas G. Martin, Youngho Seo, Bin Liu, Arun P. Wiita, Robert R. Flavell
    Clinical Cancer Research 2024 30 5
  • Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma
    Hiroki Goto, Yoshioki Shiraishi, Seiji Okada
    Exploration of Targeted Anti-tumor Therapy 2024 5 1
  • Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics
    Masayuki Munekane, Takeshi Fuchigami, Kazuma Ogawa
    Analytical Sciences 2024 40 5
  • Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment
    Tiansi Wang, Meichai Li, Ruting Wei, Xinyu Wang, Zhizhe Lin, Jianming Chen, Xin Wu
    Molecular Pharmaceutics 2024 21 3
  • The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?
    Richard L. Wahl, Brad Kahl
    Seminars in Nuclear Medicine 2024 54 4
  • Continuing progress in radioimmunotherapy for hematologic malignancies
    Hiroki Goto, Yoshioki Shiraishi, Seiji Okada
    Blood Reviews 2025 69
  • Production of medical radioisotopes via photonuclear reactions: review of candidates and opportunities for the planned radioactive ion facility at IFIN-HH
    H. SCHUBERT, R. LEONTE, S. BĂRUȚĂ, F. NEGOIȚĂ, D. NICULAE
    Romanian Reports in Physics 2024 76 2
  • Radioimmunotherapy combating biofilm-associated infection in vitro
    Zijian Ye, Berend van der Wildt, F. Ruben H. A. Nurmohamed, J. Fred F. Hooning van Duyvenbode, Jos van Strijp, H. Charles Vogely, Marnix G. E. H. Lam, Ekaterina Dadachova, Harrie Weinans, Bart C. H. van der Wal, Alex J. Poot
    Frontiers in Medicine 2024 11
  • Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy
    Bojana Bogdanovic, Florent Hugonnet, Christopher Montemagno
    Cancers 2025 17 7

Article usage

Article usage: April 2023 to April 2025

AbstractFullPdf
Apr 202326255285
May 2023446176
Jun 2023485443146
Jul 202313929450
Aug 20239337155
Sep 20235827130
Oct 20235914329
Nov 20235710930
Dec 20235110360
Jan 20244623952
Feb 20242120844
Mar 20242417483
Apr 2024757764
May 2024365642
Jun 2024658344
Jul 202418216259
Aug 202416312548
Sep 202495243
Oct 2024214531
Nov 2024305067
Dec 2024224534
Jan 202584228
Feb 2025167119
Mar 2025135434
Apr 202594756
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (6)
Journal of Nuclear Medicine
Vol. 64, Issue 6
June 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
Mark S. Longtine, Kyuhwan Shim, Mark J. Hoegger, Nadia Benabdallah, Diane S. Abou, Daniel L.J. Thorek, Richard L. Wahl
Journal of Nuclear Medicine Jun 2023, 64 (6) 924-931; DOI: 10.2967/jnumed.122.265167

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
Mark S. Longtine, Kyuhwan Shim, Mark J. Hoegger, Nadia Benabdallah, Diane S. Abou, Daniel L.J. Thorek, Richard L. Wahl
Journal of Nuclear Medicine Jun 2023, 64 (6) 924-931; DOI: 10.2967/jnumed.122.265167
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Targeted Alpha Therapy with [225Ac]Ac-Macropa-Isatuximab for CD38-positive Hematological Malignancies
  • Google Scholar

More in this TOC Section

  • Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast Cancer
  • Establishing In Vitro Dosimetric Models and Dose–Effect Relationships for 177Lu-DOTATATE in Neuroendocrine Tumors
  • Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study
Show more Basic Science Investigation

Similar Articles

Keywords

  • CD20
  • lymphoma
  • radioimmunotherapy
  • 225Ac
SNMMI

© 2025 SNMMI

Powered by HighWire